Intraovarian platelet-rich plasma injection: a potential path to genetic parenthood for women with low ovarian reserve
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20250037Keywords:
Intraovarian PRP, Low ovarian reserve , Poor ovarian response, Poseidon criterion, Donor oocyteAbstract
Background: The incidence of women with low ovarian reserve (LOR) presenting for ART is increasing. Infertility management is challenging since oocyte numbers are related to IVF success. The use of intraovarian platelet rich plasma (IOPRP) is emerging as a promising technique for ovarian rejuvenation. This study evaluates role of IOPRP in improving ovarian reserve markers, ovarian response and reproductive outcomes in women with LOR keen to achieve genetic parenthood.
Methods: This prospective observational cohort study was done on 85 women of Indian ethnicity 25-50 years, Poseidon group 3 and 4, infertility >3 years wih at least 1 previous IVF failure. One ml of PRP prepared by double centrifugation technique was injected into each ovary transvaginally. AMH, AFC, FSH, ovarian response measured pre and post IOPRP.
Results: At 8 weeks post PRP a statistically significant increase in AMH (0.57±0.33 ng/ml vs 0.96±0.49 ng/ml p<0.001), AFC (4.11±1.81 vs 7.81±3.35 p<0.001), number of oocytes retrieved (3.29±2.22 vs 5.52±3.66 p<0.001) and number of usable embryos (1.11±1.21 vs 2.33±2.12, p<0.001) was seen. Of women who underwent IVF 57.1% achieved clinical pregnancy. Overall Live birth rate was 38.09%, 8 women conceived without IVF with a live birth rate of 40%. Poseidon group 3 showed a greater improvement.
Conclusions: The study suggests that IOPRP treatment increases ovarian reserve markers and response and may be a viable alternative to donor oocytes in women with LOR wanting genetic parenthood.
Metrics
References
Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008;23(3):699-708. DOI: https://doi.org/10.1093/humrep/dem408
Labarta E, de Los Santos MJ, Escriba MJ, Pellicer A, Herraiz S. Mitochondria as a tool for oocyte rejuvenation. Fertil Steril. 2019;111(2):219-26. DOI: https://doi.org/10.1016/j.fertnstert.2018.10.036
Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2008;68(4):499-509. DOI: https://doi.org/10.1111/j.1365-2265.2007.03073.x
Camaioni A, Ucci MA, Campagnolo L, De Felici M, Klinger FG; Italian Society of Embryology, Reproduction and Research (SIERR). The process of ovarian aging: it is not just about oocytes and granulosa cells. J Assist Reprod Genet. 2022;39(4):783-92. DOI: https://doi.org/10.1007/s10815-022-02478-0
Sills ES, Wood SH. Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response. Biosci Rep. 2019;39(6):BSR20190805. DOI: https://doi.org/10.1042/BSR20190805
Venetis CA, Kolibianakis EM, Tarlatzi TB, Tarlatzis BC. Evidence-based management of poor ovarian response. Ann N Y Acad Sci. 2010;1205:199-206. DOI: https://doi.org/10.1111/j.1749-6632.2010.05665.x
Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26:1768-74. DOI: https://doi.org/10.1093/humrep/der106
Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, et al. A new more detailed stratification of low responders to ovarian stimulation: From a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105:1452-3. DOI: https://doi.org/10.1016/j.fertnstert.2016.02.005
Zuckerman S. The number of oocytes in the mature ovary. Recent Prog Horm Res. 1951;6:63-109.
Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428:145-50. DOI: https://doi.org/10.1038/nature02316
Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S, et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA. 2013;110:17474-9. DOI: https://doi.org/10.1073/pnas.1312830110
Herraiz S, Romeu M, Buigues A, Martínez S, Díaz-García C, Gómez-Seguí I, et al. Autologous stem cell ovarian transplantation to increase reproductive potential in patients who are poor responders. Fertil Steril. 2018;110:496-505. DOI: https://doi.org/10.1016/j.fertnstert.2018.04.025
Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997;55(11):1294-9. DOI: https://doi.org/10.1016/S0278-2391(97)90187-7
Marchante M, Buigues A, Ramirez-Martin N, Martinez J, Pellicer N, Pellicer A, et al. Single intraovarian dose of stem cell- and platelet-secreted factors mitigates age-related ovarian infertility in a murine model. Am J Obstet Gynecol. 2023;228(5):561.e1-561. DOI: https://doi.org/10.1016/j.ajog.2023.01.018
Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int J Mol Sci. 2020;21:7794. DOI: https://doi.org/10.3390/ijms21207794
Pantos K, Nitsos N, Kokkali G, Vaxevanoglou T, Markomichali C, Pantou A, et al. Ovarian rejuvenation and folliculogenesis reactivation in peri-menopausal women after autologous platelet-rich plasma treatment. In: Abstracts, ESHRE 32nd Annual Meeting. 2016. DOI: https://doi.org/10.26226/morressier.573c1512d462b80296c98880
Sills ES, Rickers NS, Li X, Palermo GD. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecol Endocrinol. 2018;34:756-60. DOI: https://doi.org/10.1080/09513590.2018.1445219
Sfakianoudis K, Simopoulou M, Nitsos N, Rapani A, Pappas A, Pantou A, et al. Autologous Platelet-Rich Plasma Treatment Enables Pregnancy for a Woman in Premature Menopause. J Clin Med. 2018;8:1.
Cakiroglu Y, Saltik A, Yuceturk A, Karaosmanoglu O, Kopuk SY, Scott RT, et al. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging. 200020;12:10211-22. DOI: https://doi.org/10.18632/aging.103403
Petryk N, Petryk M. Ovarian rejuvenation through platelet-rich autologous plasma (PRP): a chance to have a baby without donor eggs, improving the life quality of women suffering from early menopause without synthetic hormonal treatment. Reprod Sci. 2020;27:1975-82. DOI: https://doi.org/10.1007/s43032-020-00266-8
Melo P, Navarro C, Jones C, Coward K, Coleman L. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study. J Assist Reprod Genet. 2020;37:855-63. DOI: https://doi.org/10.1007/s10815-020-01710-z
Farimani M, Nazari A, Mohammadi S, Anvari Aliabad R. Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria. Reprod Biol Endocrinol. 2021;19:137. DOI: https://doi.org/10.1186/s12958-021-00826-w
Sills E, Rickers NS, Svid CS, Rickers JM, Wood SH. Normalized ploidy following 20 consecutive blastocysts with chromosomal error: healthy 46, XY pregnancy with IVF after intraovarian injection of autologous enriched platelet-derived growth factors. Int J Mol Cell Med. 2019;8:84-90.
Mehri. Intraovarian platelet-rich plasma administration could improve blastocyst euploidy rates in women undergoing in vitro fertilization. Clin Exp Reprod Med. 2022;49(3):210-4. DOI: https://doi.org/10.5653/cerm.2021.05057
Barad DH, Albertini DF, Molinari E, Gleicher N. Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study. Hum Reprod Open. 2022;2022(3):hoac027. DOI: https://doi.org/10.1093/hropen/hoac027
Herlihy NS, Cakiroglu Y, Whitehead C, Reig A, Tiras B, Scott Jr RT, et al. Effect of intraovarian platelet-rich plasma injection on IVF outcomes in women with poor ovarian response: the PROVA randomized controlled trial. Human Reproduction. 2024:deae093. DOI: https://doi.org/10.1093/humrep/deae093
Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360(6):606-14. DOI: https://doi.org/10.1056/NEJMcp0808697
Dattani S, Rodés-Guirao L, Ritchie H, Ortiz-Ospina E, Roser M. Life Expectancy. OurWorldInData.org. 2023. Available from: https://ourworldindata.org/life-expectancy. Accessed on 18 August 2024.
Golezar S, Ramezani Tehrani F, Khazaei S, Ebadi A, Keshavarz Z. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric. 2019;22(4):403-11. DOI: https://doi.org/10.1080/13697137.2019.1574738
Gonda KJ, Domar AD, Gleicher N, Marrs RP. Insights from clinical experience in treating IVF poor responders. Reprod Biomed Online. 2018;36(1):12-9. DOI: https://doi.org/10.1016/j.rbmo.2017.09.016
Sfakianoudis K, Simopoulou M, Nitsos N, Rapani A, Pappas A, Pantou A, et al. Autologous platelet-rich plasma treatment enables pregnancy for a woman in premature menopause. J Clin Med. 2018;8(1):1. DOI: https://doi.org/10.3390/jcm8010001
Hosseini L, Shirazi A, Naderi MM, Shams-Esfandabadi N, Borjian Boroujeni S, Sarvari A, et al. Platelet-rich plasma promotes the development of isolated human primordial and primary follicles to the preantral stage. Reprod Biomed Online. 2017;35(4):343-50. DOI: https://doi.org/10.1016/j.rbmo.2017.04.007
Seckin S, Ramadan H, Mouanness M, Kohansieh M, Merhi Z. Ovarian response to intraovarian platelet-rich plasma (PRP) administration: hypotheses and potential mechanisms of action. J Assist Reprod Genet. 2022;39(1):37-61. DOI: https://doi.org/10.1007/s10815-021-02385-w
McGee EA, Hsueh AJW. Initial and Cyclic Recruitment of Ovarian Follicles. Endocrine Rev. 2000;21(2):200-14. DOI: https://doi.org/10.1210/edrv.21.2.0394
Ahmadian S, Sheshpari S, Pazhang M, Bedate AM, Beheshti R, Abbasi MM, et al. Intra-ovarian injection of platelet-rich plasma into ovarian tissue promoted rejuvenation in the rat model of premature ovarian insufficiency and restored ovulation rate via angiogenesis modulation. Reprod Biol Endocrinol. 2020;18:1-13. DOI: https://doi.org/10.1186/s12958-020-00638-4
Wood SH, Sills ES. Intraovarian vascular enhancement via stromal injection of platelet-derived growth factors: Exploring subsequent oocyte chromosomal status and in vitro fertilization outcomes. Clin Exp Reprod Med. 2020;47(2):94-100. DOI: https://doi.org/10.5653/cerm.2019.03405
Callejo J, Salvador C, González-Nuñez S, Almeida L, Rodriguez L, Marqués L, et al. Live birth in a woman without ovaries after autograft of frozen-thawed ovarian tissue combined with growth factors. J Ovarian Res. 2013;6(1):33. DOI: https://doi.org/10.1186/1757-2215-6-33
Martínez de Toda I, Ceprián N, Díaz-Del Cerro E, De la Fuente M. The role of immune cells in oxiinflamm-aging. Cells. 2021;10(11):2974. DOI: https://doi.org/10.3390/cells10112974
Keefe DL, Franco S, Liu L, Trimarchi J, Cao B, Weitzen S, et al. Telomere length predicts embryo fragmentation after in vitro fertilization in women-toward a telomere theory of reproductive aging in women. Am J Obstet Gynecol. 2005;192:1256-60. DOI: https://doi.org/10.1016/j.ajog.2005.01.036
Barrenetxea G, Celis R, Barrenetxea J, Martínez E, De Las Heras M, Gómez O, Aguirre O. Intraovarian platelet-rich plasma injection and IVF outcomes in patients with poor ovarian response: a double-blind randomized controlled trial. Hum Reprod. 2024;39(4):760-9. DOI: https://doi.org/10.1093/humrep/deae038
Mejia-Gomez J, Shaltout O, Alkhanbouli M, Shaltout N, Philippopoulos E, Wolfman W, et al. First Case Report of Bacteremia and Bilateral Ovarian Abscesses Post Ovarian Platelet Rich Plasma Injection. Gynecological Reproduct Endocrinol Metabolism. 2024;4(2):097-101.
Downloads
Published
How to Cite
Issue
Section
